Abstract

The utility of AI within drug discovery and pre-clinical development heralds a new era of innovation in biomedical research. In the complex journey from the lab bench to the patient’s bedside, the preclinical phase stands as a pivotal crossroad where potential drug candidates are identified, validated and rigorously analyzed before potential clinical testing in patients.